Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use
Condition(s):Relapsed Multiple MyelomaLast Updated:March 9, 2022Completed